Form 4/A for MAIA MAIA Biotechnology, Inc.

Accepted 2025-03-05 00:00:00 ET · period of report 2025-02-24 · accession 0001127602-25-008322 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DAI	2025-03-05	2025-02-24	MAIA	Smith Stan	Dir	P - Purchase	$1.50	+50.0K	1.18M	+4%	+$75.0K
DAI	2025-03-05	2025-02-24	MAIA	Smith Stan	Dir	P - Purchase	$1.87	+50.0K	50.0K	New	+$93.5K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-02-24	P	A	50,000	$1.50	1,180,060	I See Footnote	—	—	(F1) The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025. (F2) These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
2	Derivative	Warrants	2025-02-24	P	A	50,000	$1.87	50,000	I See Footnote	$1.87 · 2026-02-24 to 2031-02-24	50,000 Common Stock	(F3) This Form 4/A is being filed to correct the "Date Exercisable" and "Expiration Date" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 3 to "February 24, 2025". (F4) These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on February 24, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the inital issuance date. (F5) These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.